(E)-Alkenes as replacements of amide bonds: development of novel and potent acyclic CGRP receptor antagonists

Abstract

A new class of CGRP receptor antagonists was identified by replacing the central amide of a previously identified anilide lead structure with ethylene, ethane, or ethyne linkers. (E)-Alkenes as well as alkynes were found to preserve the proper bioactive conformation of the amides, necessary for efficient receptor binding. Further exploration resulted in several potent compounds against CGRP-R with low susceptibility to P-gp mediated efflux.

Keywords: (E)-Alkene; CGRP; Migraine; P-gp.